3-Amino-n-(2-methylpropyl)propanamide hydrochloride, 95+%, 500mg

Ethyl 3,4-dibromobenzoate, 95.0%, 2g

N-(3-Chlorobenzyl)-2-butanamine hydrochloride, 95.0%, 5g

methyl 2-[1-(bromomethyl)cyclopropyl]acetate, 2949.000, 100mg

tert-Butyl 6-(difluoromethyl)-5-fluoro-8-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate, 98%, 1g

Accessori Cartucce filtranti di ricambio HPLC, 10 µm, 1 pezzo

2,2'-Bis[bis(3,5-dimethylphenyl)phosphino]-1,1'-biphenyl>98.0%(GC)500mg

2-Bromo-4-methyl-1-(propan-2-yl)benzene, 98%, 1g

(E)-METHYL 5-(4-METHYLPHENYLSULFONAMIDO)PENT-2-ENOATE, 95.0%, 250mg

4-(4-nitrophenyl)-2,3-dihydro-1H-1,5-benzodiazepine, 95.0%, 2g

N-idrossisuccinimmide, min 99%, per sintesi, 100 g, confezione in vetro

2-Hydroxy-3-methylbenzonitrile, 95.0%, 10g

1,1,1,3,3,3-Hexafluoroisopropyl methacrylate (stabilized with MEHQ), 99.0%, 5g